Latest filing published 28 Feb 2020 for IRLAB Therapeutics AB, €7,987.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Eva Lindgren: trading record in brief
All filings by Eva Lindgren on record concern IRLAB Therapeutics AB. In total, 5 filings cover trades dated from 24 February 2017 to 26 February 2020.
On the market, this insider has only ever bought: 1 purchase, €42k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 28 February 2020 came the latest disclosure, a transaction for €7,987 in IRLAB Therapeutics AB. The clock since the last published purchase (28 February 2017) now reads 3,540 days. Filings reach the Finansinspektionen feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Eva Lindgren
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,130 shares@ SEK 27.0035.6% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-6353ff7587cee2741b09
- 5,666 shares@ SEK 27.0064.4% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-6a83f314eb05720d3430
- 19,384 shares@ SEK 88.71AktieISIN SE0012675379FI:csv-64d899cfb9153525c6ae
- 6,666 shares@ SEK 60.00FI:csv-2ac59906cb94c4d21feeCanonical exit: 25 May 2017 (T+90)
4 of 4 declarations